122 related articles for article (PubMed ID: 38800047)
1. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] Knockdown of circ_0001883 may inhibit epithelial‑mesenchymal transition in laryngeal squamous cell carcinoma via the miR‑125‑5p/PI3K/AKT axis.
Chen F; Lao Z; Zhang H; Wang J; Wang S
Exp Ther Med; 2024 Apr; 27(4):129. PubMed ID: 38414792
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer.
Liu T; Liang X; Sun Y; Yang S
Exp Ther Med; 2024 Jan; 27(1):1. PubMed ID: 38125358
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.
Si F; Sun J; Wang C
Exp Ther Med; 2021 Oct; 22(4):1090. PubMed ID: 34504544
[TBL] [Abstract][Full Text] [Related]
5. Retracted: G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9792473. PubMed ID: 37947004
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction].
Int J Gen Med; 2023; 16():5159-5160. PubMed ID: 37954653
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] miR‑29b enhances the proliferation and migration of bone marrow mesenchymal stem cells in rats with castration‑induced osteoporosis through the PI3K/AKT and TGF‑β/Smad signaling pathways.
Wang Y; Han X; Zang T; Kang P; Jiang W; Niu N
Exp Ther Med; 2022 Dec; 24(6):708. PubMed ID: 36382095
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
Mei XL; Zhong S
Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] miR‑613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.
Su X; Gao C; Feng X; Jiang M
Exp Ther Med; 2023 Dec; 26(6):547. PubMed ID: 37928508
[TBL] [Abstract][Full Text] [Related]
11. Retracted: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition.
Engineering JOH
J Healthc Eng; 2022; 2022():9864791. PubMed ID: 36619243
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-451a prevents cutaneous squamous cell carcinoma progression via the 3-phosphoinositide-dependent protein kinase-1-mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2021 Feb; 21(2):116. PubMed ID: 33335579
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
Markers D
Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
[TBL] [Abstract][Full Text] [Related]
14. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
Huang X; Zhang S; Wang W
Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984
[TBL] [Abstract][Full Text] [Related]
15. Retracted: si-PDGFR
Longevity OMAC
Oxid Med Cell Longev; 2024; 2024():9839740. PubMed ID: 38236530
[TBL] [Abstract][Full Text] [Related]
16. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
Markers D
Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
[TBL] [Abstract][Full Text] [Related]
17. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
Engineering JOH
J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Pingyangmycin Activates Oral Carcinoma Cell Autophagy via the Phosphorylation of the PI3K/AKT/mTOR Axis to Achieve the Purpose of Treating Oral Carcinoma.
International EM
Emerg Med Int; 2024; 2024():9795172. PubMed ID: 38298946
[TBL] [Abstract][Full Text] [Related]
19. Retracted: CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9860912. PubMed ID: 37416241
[TBL] [Abstract][Full Text] [Related]
20. Retracted:
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9817815. PubMed ID: 37565156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
